Now, WHO is recommending widespread use of the Mosquirix, a new vaccine by GlaxoSmithKline which rouses a child’s immune system to thwart Plasmodium falciparum, the deadliest of five malaria pathogens and the most prevalent in Africa. The vaccine is not just a first for malaria — it is the first developed for any parasitic disease.
